security check required facebookjoin or log into facebook   email or phonepasswordforgot accountlog indo you want to join facebooksign upsign upsecurity checkplease enter the text belowcant read the text abovetry another text or an audio captchatext in the boxwhats thissecurity checkthis is a standard security test that we use to prevent spammers from creating fake accounts and spamming userssubmitenglish usespañolfrançais franceالعربيةportuguês brasilitaliano한국어deutschहिन्दीmessengerfacebook litepeopleplacesgameslocationscelebritiesmarketplacegroupsrecipesmomentsinstagramaboutcreate adcreate pagedeveloperscareersprivacycookiesad choicestermssettingsactivity log facebook   coleman more brands coleman® esky® aerobed® sevylor™ stearns® puddle jumper® search catalog search menu the coleman company inc english north america united states english canada english français australia australia english south america brazil português my account login  register login  register login register email sign up search catalog search  promotions             stoves shelters  canopies tents marine coolers get outdoors and get active cook camp explore picnic your browsers javascript functionality is turned off please turn it on so that you can experience the full capabilities of this site enter your email   the coleman company inc all rights reserved blaise coleman endo pharmaceuticals holdings inc evp  cfo  redbooks brands marketers agencies search less sell more    sign in get a free trial    contact us   blaise coleman evp  cfo endo pharmaceuticals holdings inc email realtime sales trigger feed  generated by redbooks machine learning and natural language processing technology tracking  news sources to aggregate all new executives jobrole changes and news on decision makers brands and agencies in the mediamarketing industry this sales feed is for blaise coleman at endo pharmaceuticals holdings inc blaise coleman works as evp  cfo  acting in a executive management role  endo pharmaceuticals holdings inc is a leader in pharmaceuticals  health care products  redbooks tracks personnel changes for advertisers spending over  million annually for more executive management leads or mediamarketing prospecting automation start a free trial now recent related news  cantor’s first take bullish on valeant pharmaceuticals intl inc vrx sidelined on endo international endp  therefore even though the analyst appreciates the firm even boasts “one of the best management teams in the industry” she initiates coverage on endo with a neutral rating and a price target of  which represents an  increase from where the stock is currently trading “paul campanelli blaise coleman and terrance coughlin have all successfully grown other established generics companies that said uncertainty regarding endo’s earnings potential in  keeps us on the sidelines for now  people in this article blaise coleman  paul v campanelli  terrance j coughlin  endo international plc endp q  results  earnings call transcript  good morning and thank you for joining us to discuss our first quarter  financial results joining me on todays call are paul campanelli president and ceo of endo and blaise coleman executive vice president and chief financial officer we have prepared a slide presentation to accompany todays webcast and that presentation as well as other materials are posted online in the investor section at wwwendocom  people in this article blaise coleman  paul v campanelli  stephen mock learn more about blaise coleman and  key contacts   create targeted lead lists   gain insider knowledge with advanced machine  learning   realtime verified contact info enter work email please enter email address please enter valid email address learn more about blaise coleman and  key contacts first name  please enter first name last name  please enter last name company name  please enter company name email  phone  please enter phone number please enter  digits number what industry are you in    please select one the categories below please enter value for the industry  media sales  production  adtechmartech  sponsorship sales   agency new business   other what is your role    please select one the categories below please enter value for the role   csuite   vpmanager   sales rep   other thank you for registering for a free redbookscom trial we are processing your request and will be in touch shortly to get you started for immediate assistance please call us at   or email us at inforedbookscom home learn more free trial features ad think events thought leadership events top advertiser directory top agency directory add your agency update your agency agency showcase advertising associations creative spotlight services and suppliers about us blog contact us jobs terms  conditions privacy policy customer support   connect with us copyright   red books llc all rights reserved endp blaise coleman insider trades for endo international plc bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close endo international plc nasdaq endp go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus endo international plc after hours  quotes are delayed by  min jul    pm endp quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual blaise coleman mr blaise coleman is chief financial officer  executive vice president at endo international plc he received his undergraduate degree from widener university and an mba from the fuqua school of business transactions date shares transaction value     derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      award at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr paul v campanelli president chief executive officer  director mr terrance j coughlin chief operating officer  executive vice president mr blaise coleman chief financial officer  executive vice president dr robert j cobuzzi svpoperations research  development strategy mr brandon rockwell vice presidentbusiness development ms jennifer e dubas vice president  chief compliance officer dr matthew w davis svpresearch  development branded pharmaceuticals mr patrick barry senior vice presidentus branded mr rahul garella svphead of international pharmaceuticals mr joseph a barbarite evpglobal quality  compliance dr hermanth jacob varghese executive vpcorporate development  strategy mr todd benjamin sisitsky director mr douglas s ingram director mr daniel a rudio chief accounting officer vp  controller mr stephen j mock svpinvestor relations  corporate affairs mr larry cunningham executive vice presidenthuman resources ms orla dunlea secretary mr matthew joseph maletta chief legal officer  executive vice president mr roger h kimmel chairman mr michael hyatt independent director mr shane m cooke independent director ms jill d smith independent director mr william patrick montague independent director dr nancy j hutson independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume aftse  under pressure as bt pushed lower afrances cac  falls  dropping further in early friday trade abarclays falls  after earnings report abritish airways parent iag rises  after quarterly profit report abritish airways parent iags profit soars agermanys dax opens  lower at  afrances cac  opens  lower at  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  endo international plc  endp stock price quote at ally invest quotes snapshot  endpendo international plc endpnasdaqset alertoptionsstreaming chartslast pricenasdaq previous close  last trade as of pm et todays changebid size ask size day low  high  volume ksellbuysnapshotchartsnewsoptionsearningsfundamentalsfinancialsinsiders view advanced chart mountain ohlc candlestick line chart style download historical data   view pharmaceuticals other industrypeer comparison as of  day day month month year year yeartimeframe endo international plc  nasdaq price change  volume  k sellbuydetailed quoteset alertoptions chain horizon pharma plc  nasdaq price change  volume  k sellbuydetailed quoteset alertoptions chain amarin corporation plc  nasdaq price change  volume  k sellbuydetailed quoteset alertoptions chain icon plc  nasdaq price change  volume  k sellbuydetailed quoteset alertoptions chain jazz pharmaceuticals plc  nasdaq price change  volume  k sellbuydetailed quoteset alertoptions chain read more news recent news update endo sees realizing mm in annual net run rate pretax cost savings by qam et  benzingaâš  benzingacom benzinga does not provide investment advice all rights reservedupdate endo sees restructuring actions to reduce cos workforce by  positions result in pretax charge of mam et  benzingaâš  benzingacom benzinga does not provide investment advice all rights reservedshareholder alert pomerantz law firm investigates claims on behalf of investors of endo international plc  endppm et  business wireendp investor alert the law offices of vincent wong reminds investors of an investigation involving possible securities fraud violations by the board of directors of endo international plcam et  business wire view all commentary and analysis is the fda biotechs best friendam et  seeking alphaearnings preview valeant pharmaceuticalsam et  seeking alphainsys guilty pleas get closer to former ceopm et  seeking alphaq biotech catalyst watch key pdufas part pm et  seeking alpha company profile business descriptionendo international plc operates as a pharmaceutical company it focuses on developing manufacturing and distributing of branded and generic pharmaceutical products the company operates through the following segments us branded pharmaceuticals us generic pharmaceuticals and international pharmaceuticals the us branded pharmaceuticals offers products that focus on the treatment and management of conditions in urology urologic oncology endocrinology and orthopedics the us generic pharmaceuticals segment consist of a differentiated product portfolio including highbarriertoentry products firsttofile or firsttomarket opportunities that are difficult to formulate difficult to manufacture or face complex legal and regulatory challenges the international pharmaceuticals segment includes a variety of pharmaceutical products for the canadian latin american south african and world markets endo international was founded on october   and is headquartered dublin ireland view company web site for more detailsaddressminerva housedublin dublin phonenumber of employeesrecent sec filingk president chief executive officer  directorpaul v campanellichief operating officer  executive vice presidentterrance j coughlinchief financial officer  executive vice presidentblaise colemansvpoperations research  development strategyrobert j cobuzzi company highlights price openprevious close week range  market capitalization bshares outstanding msectorhealth technologyindustrypharmaceuticals othernext earnings announcement options summary call open interest dput open interest dcall volume dput volume dput call open interest ratio dput call volume ratio d data delayed by up to  minutes view all fundamentalsfundamentals price  earningsnaearnings per sharebeta vs sp revenue bnet profit marginreturn on equity analyst ratings as of buyoverweightholdunderweightsellconsensus recommendationpowered by factset   unavailable  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries this feature is temporarily unavailable copyright – fmr llc  all rights reserved  terms of use privacy security site map  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft endp stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsendp endo international plc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all us senator expands opioid probe to distributors drugmakers reuters –  pm et  us democratic senator claire mccaskill on thursday expanded an investigation into the causes of the opioid crisis plaguing the country seeking information from four more drugmakers and three drug distributors senator expands probe into opioid addiction crisis  nd update dj business news –  am et  the topranking democrat on the senate homeland security and governmental affairs committee expanded a probe into the opioid addiction crisis asking four more drug companies and three drug distributors to provide documents claire mccaskill sent letters wednesday to drugmakers mallinckrodt plc mnk endo international plc endp teva pharmaceutical industries ltd teva and allergan plc agn as well as to distributors mckesson corp mck amerisourcebergen corp abc and cardinal health inc briefus senator claire mccaskill opioid investigation expands to include distributors and additional manufacturers‍​ reuters –  am et  allergan plc senator expands probe into opioid addiction crisis dj business news –  am et  the topranking democrat on the senate homeland security and governmental affairs committee on wednesday expanded a probe into the opioid addiction crisis asking four more drug companies and three drug distributors to provide documents claire mccaskill sent letters to drugmakers mallinckrodt plc mnk endo international plc endp teva pharmaceutical industries ltd teva and allergan plc agn as well as to distributors mckesson corp mck amerisourcebergen corp abc and cardinal health inc endo to shut alabama operations cut  pct of workforce reuters –  am et  endo international plc endp said on friday it would shutter its manufacturing and distribution facilities in huntsville alabama resulting in a workforce reduction of about  percent the drugmaker which employed  people as of feb  said it would layoff  employees and incur a pretax charge of about  million briefendo to restructure manufacturing network reuters –  am et  endo international plc endp  endo endp to restructure manufacturing network  endo endp to restructure manufacturing network  endo international plc endp  closure of facilities is expected to take place over next  to  months endo to cut  jobs and close facilities in alabama marketwatch –  am et  endo international plc endp said friday it was cutting  jobs which is about  of its workforce as part of a restructuring aimed at cutting costs by up to  million a year the pharmaceutical company said it will close manufacturing and distribution facilities in huntsville ala over the next  to months as a result of declining volumes of commoditized products endo endp expects to record restructuring charges of  million including cash charges of  million endo expects about  mln to  mln in annual net run rate pretax savings by q  marketwatch –  am et  endo to book pretax charge of about  mln including about  mln of cash charges marketwatch –  am et  endo to close manufacturing distribution facilities in alabama in next  to  months marketwatch –  am et  endo to restructure manufacturing network pr newswire –  am et  dublin july    endo international plc endp today announced that after completing a comprehensive review of its manufacturing network the company will be ceasing operations and closing its manufacturing and distribution facilities in huntsville alabama the closure of the facilities is expected to take place over the next  to  months technical reports on drug makers equities  teva pharma endo ionis pharma and amarin pr newswire –  am et  new york july   if you want a stock review on teva endp ions or amrn then come over to httpdailystocktrackercomregister and sign up for your free customized report today httpdailystocktrackercomregister teva pharma  on monday shares in petach tikva israel headquartered teva pharmaceutical industries ltd teva saw a slight decline of  ending the day at  the stock endo to announce secondquarter  financial results pr newswire –  am et  dublin july   endo international plc endp will announce its secondquarter  financial results on tuesday august   the dialin number to access the call is uscanada  international  and the passcode is  endo pulls opioid as us seeks to tackle abuse epidemic reuters –  pm et   fda requested withdrawal of drug in june  endo endp expects to incur impairment charge of  mln  endo endp shares down as much as  percent endo international plc endp said on thursday it agreed to withdraw its longacting opioid painkiller opana er from the market after the us food and drug administration declared its benefit did not outweigh public health risks associated with opioid abuse endo will remove opioid from market following fda request marketwatch –  pm et  endo international plc endp said on thursday that it will voluntarily remove the opioid pain medication opana er from the market in response to a food and drug administration request last month endo endp expects an about  million pretax impairment charge in the second quarter to writeoff the remaining net book value of its opana er intangible asset opana er sales amounted to about  million last year and nearly  million in the first quarter the company said endo expects removing opana er from market will cost  mln impairment charge in q marketwatch –  pm et  endo will remove opioid from market following fda request marketwatch –  pm et  endo to voluntarily remove opioid painkiller in us reuters –  pm et  endo international plc endp said it would voluntarily remove its longlasting opioid painkiller opana er a month after the us food and drug administrations withdrawal request amid the growing opioid abuse crisis in the united states endos endp shares fell  percent to  in afternoon trading on thursday briefendo decides to voluntarily remove opana er from market reuters –  pm et  endo international plc endp   endo endp provides update on opana® er  endo internationalafter consideration consultation with us fda following withdrawal request company has decided to voluntarily remove opana er from market  endo international plc endp  expects to incur a pretax impairment charge of approximately  million in q of  endo provides update on opana® er pr newswire –  pm et  dublin july    endo international plc endp continues to believe in the safety efficacy and favorable benefitrisk profile of opana® er when used as intended and notes that the company has taken significant steps over the years to combat misuse and abuse page page   next  todays and upcoming events aug  endp to announce q earnings before market confirmed aug  endp earnings conference call at  am listen past events last  days jun  shareholders meeting data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe endo announces appointment of blaise coleman as chief financial officerhomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets open in  hrs  minssp futures dow futures nasdaq futures endo announces appointment of blaise coleman as chief financial officerpr newswiredecember  reblogsharetweetsharedublin dec   prnewswire  endo international plc nasdaq  tsx endp announced today that it has appointed blaise coleman as executive vice president and chief financial officer effective december   mr coleman has been serving as endos interim chief financial officer since november  after a thorough assessment and search process endos board of directors has concluded that mr coleman is the strongest candidate for the position and i could not be more pleased blaise and i have built a strong working relationship over the past  months so im excited to officially have blaise permanently join the endo executive leadership team said paul campanelli president and chief executive officer of endo in addition to his years of company experience blaise brings significant industry experience a successful track record of delivering value and strong leadership skills to his role we look forward to his continued contributions to our companymr coleman joined endo in january  as vice president of corporate financial planning  analysis and was then promoted to senior vice president global finance operations in november  prior to joining endo mr coleman held a number of finance leadership roles with astrazeneca a global biopharmaceutical company most recently as the chief financial officer of the astrazenecabristolmyers squibb us diabetes alliance prior to that he was the head of finance for the astrazeneca global medicines development organization based in mölndal sweden mr coleman joined astrazeneca in  as senior director commercial finance for the us cardiovascular business he joined astrazeneca from centocor a wholly owned subsidiary of johnson  johnson where he held positions in both the licenses  acquisitions and commercial finance organizations mr colemans move to centocor in early  followed  years experience with the global public accounting firm pricewaterhousecoopers llp mr coleman is a certified public accountant he holds a bachelor of science degree in accounting from widener university and an mba from the fuqua school of business at duke universityi would like to thank paul and the board for their continued confidence and i am excited to serve endo our employees shareholders and customers in my new role said mr coleman i look forward to supporting the team as we continue our efforts to refocus and grow the business and prepare to execute on our new corporate strategy in about endo international plcendo international plc nasdaq  tsx endp is a global specialty pharmaceutical company focused on improving patients lives while creating shareholder value endo develops manufactures markets and distributes quality branded and generic pharmaceutical products as well as overthecounter medications though its operating companies endo has global headquarters in dublin ireland and us headquarters in malvern pa learn more at wwwendocomcautionary note regarding forwardlooking statementsthis press release contains forwardlooking statements including but not limited to the statements by messrs campanelli and coleman as well as endos expected estimated or anticipated future results because forecasts are inherently estimates that cannot be made with precision endos performance at times differs materially from its estimates and targets and endo often does not know what the actual results will be until after the end of the applicable reporting period therefore endo will not report or comment on its progress during a current quarter except through public announcement any statement made by others with respect to progress during a current quarter cannot be attributed to endo  all forwardlooking statements in this press release reflect endos current analysis of existing trends and information and represent endos judgment only as of the date of this press release  if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize actual results could vary materially from endos expectations and projections risks and uncertainties include among other things general industry and market conditions technological advances and patents attained by competitors challenges inherent in the research and development and regulatory processes challenges related to product marketing such as the unpredictability of market acceptance for new products andor the acceptance of new indications for such products inconsistency of treatment results among patients potential difficulties in manufacturing general economic conditions and governmental laws and regulations affecting domestic and foreign operations endo expressly disclaims any intent or obligation to update these forwardlooking statements except as required by law additional information concerning these and other risk factors can be found in endos periodic reports filed with the us securities and exchange commission and in canada on the system for electronic data analysis and retrieval sedar including current reports on form k quarterly reports on form q and annual reports on form k  additional information about endo is available on the world wide web at wwwendocom or you can contact the endo investor relations department by calling  read moreto view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesendoannouncesappointmentofblaisecolemanaschieffinancialofficerhtmlreblogsharetweetsharerecently viewedyour list is emptywhat to read nextverizon soars on beat starbucks big china deal astrazeneca sinks as drug trial disappointsyahoo financethis will be in everyones household by banyan hillsponsoredjohn elway promoted to president of football operationsgmprofootball talk on nbc sportsastrazeneca again a consolidation target after drug trial disappointmentthe streetwind projects in peril as indian states rethink purchasesbloombergzuckerberg wifes ambitious secret finally exposedunewzmesponsoredamazon surpasses b mark bezos briefly becomes the world’s richest personinvestopediatrump’s unwitting legacy could be universal health coverageyahoo financesean hannity responds to claim he ran up a  tab at trumps hotel after flying in a yearold lobster from mainebusiness insiderengineer finds pattern makes millions in stocksmoney morningsponsoredmattis was on vacation when trump tweeted transgender ban and he was reportedly appalled by itbusiness insidertwitter is only famous now because of president trump nyse traderyahoo finance videogdp — what you need to know in markets on fridayyahoo financeshop july specials at macys  extra  offmacyscomsponsoredrepublicans kill the border taxyahoo financeamazon ploughs ahead with high sales and spending profit plungesreutersdonald trump hovers over melania during a speech as only trump cananonymous i put  years in the service  i find it nearly impossible to feel even an inkling of patriotism when i see this potus adorning any military patch or regalia he violates his oath he hates so many classes of people he does not understand classified categories mean he does not know the difference between taking up arms and bullying people or nations absolutely relieved that i would not have to put my life on the line for a person who believes there is no line between right and wrong god save and bless americajoin the conversation  k endo announces appointment of blaise coleman as chief financial officer endo announces appointment of blaise coleman as chief financial officer news provided by endo international plc dec    et share this article dublin dec   prnewswire  endo international plc nasdaq  tsx endp announced today that it has appointed blaise coleman as executive vice president and chief financial officer effective december   mr coleman has been serving as endos interim chief financial officer since november   after a thorough assessment and search process endos board of directors has concluded that mr coleman is the strongest candidate for the position and i could not be more pleased blaise and i have built a strong working relationship over the past  months so im excited to officially have blaise permanently join the endo executive leadership team said paul campanelli president and chief executive officer of endo in addition to his years of company experience blaise brings significant industry experience a successful track record of delivering value and strong leadership skills to his role we look forward to his continued contributions to our company mr coleman joined endo in january  as vice president of corporate financial planning  analysis and was then promoted to senior vice president global finance operations in november  prior to joining endo mr coleman held a number of finance leadership roles with astrazeneca a global biopharmaceutical company most recently as the chief financial officer of the astrazenecabristolmyers squibb us diabetes alliance prior to that he was the head of finance for the astrazeneca global medicines development organization based in mölndal sweden mr coleman joined astrazeneca in  as senior director commercial finance for the us cardiovascular business he joined astrazeneca from centocor a wholly owned subsidiary of johnson  johnson where he held positions in both the licenses  acquisitions and commercial finance organizations mr colemans move to centocor in early  followed  years experience with the global public accounting firm pricewaterhousecoopers llp mr coleman is a certified public accountant he holds a bachelor of science degree in accounting from widener university and an mba from the fuqua school of business at duke university i would like to thank paul and the board for their continued confidence and i am excited to serve endo our employees shareholders and customers in my new role said mr coleman i look forward to supporting the team as we continue our efforts to refocus and grow the business and prepare to execute on our new corporate strategy in  about endo international plc endo international plc nasdaq  tsx endp is a global specialty pharmaceutical company focused on improving patients lives while creating shareholder value endo develops manufactures markets and distributes quality branded and generic pharmaceutical products as well as overthecounter medications though its operating companies endo has global headquarters in dublin ireland and us headquarters in malvern pa learn more at wwwendocom cautionary note regarding forwardlooking statements this press release contains forwardlooking statements including but not limited to the statements by messrs campanelli and coleman as well as endos expected estimated or anticipated future results because forecasts are inherently estimates that cannot be made with precision endos performance at times differs materially from its estimates and targets and endo often does not know what the actual results will be until after the end of the applicable reporting period therefore endo will not report or comment on its progress during a current quarter except through public announcement any statement made by others with respect to progress during a current quarter cannot be attributed to endo  all forwardlooking statements in this press release reflect endos current analysis of existing trends and information and represent endos judgment only as of the date of this press release  if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize actual results could vary materially from endos expectations and projections risks and uncertainties include among other things general industry and market conditions technological advances and patents attained by competitors challenges inherent in the research and development and regulatory processes challenges related to product marketing such as the unpredictability of market acceptance for new products andor the acceptance of new indications for such products inconsistency of treatment results among patients potential difficulties in manufacturing general economic conditions and governmental laws and regulations affecting domestic and foreign operations endo expressly disclaims any intent or obligation to update these forwardlooking statements except as required by law additional information concerning these and other risk factors can be found in endos periodic reports filed with the us securities and exchange commission and in canada on the system for electronic data analysis and retrieval sedar including current reports on form k quarterly reports on form q and annual reports on form k  additional information about endo is available on the world wide web at wwwendocom or you can contact the endo investor relations department by calling   to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesendoannouncesappointmentofblaisecolemanaschieffinancialofficerhtml source endo international plc related links httpwwwendocom dec    et preview endo announces appointments and updates to executive management team dec    et preview endo to present at the th annual jp morgan healthcare conference my news release contains wide tables view fullscreen also from this source jul    et endo to restructure manufacturing network jul    et endo to announce secondquarter  financial results explore more news releases in similar topics health care  hospitals medical pharmaceuticals pharmaceuticals personnel announcements you just read endo announces appointment of blaise coleman as chief financial officer news provided by endo international plc dec    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search